An iPSC-based Platform for Characterization of Neuronal Circuit Dysfunction in RASopathies

Awardee: Sattar Khoshkhoo

Institution: Brigham and Women's Hospital

Grant Amount: $58,222

Funding Period: February 1, 2025 - January 31, 2026


Summary:

RASopathies are a group of genetic disorders that affect multiple body systems and are often linked to neurocognitive issues like learning disabilities, autism, and epilepsy. These conditions arise due to overactive Ras-MAPK signaling, which plays a crucial role in brain development and function. However, the specific effects of Ras-MAPK overactivation on brain circuits are not well understood. This project aims to use patient-derived stem cells to model RASopathies and investigate how abnormal signaling impacts brain cell communication. Moreover, by testing drugs that inhibit the Ras-MAPK pathway, this proposal will evaluate the feasibility of using Ras-MAPK inhibitors as a therapeutic strategy to restore normal brain activity in affected individuals. This research platform will also enable future drug discovery for rare genetic diseases that affect brain circuits.

Previous
Previous

Epilepsy linked toTBC1D24 Loss: pH-Targeted Pharmacological and Nanotechnological Interventions

Next
Next

Investigating SETBP1 pathogenic variants in lung malformation and function using human induced pluripotent stem cell-derived organoids